| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 116.16M | 109.99M | 107.16M | 104.82M | 101.80M | 77.91M |
| Gross Profit | 65.64M | 63.23M | 60.03M | 59.73M | 54.56M | 43.94M |
| EBITDA | 18.70M | 17.46M | 15.62M | 17.25M | 18.78M | 13.73M |
| Net Income | 7.12M | 6.51M | 5.79M | 6.69M | 8.49M | 4.05M |
Balance Sheet | ||||||
| Total Assets | 75.71M | 79.24M | 73.97M | 80.25M | 78.97M | 80.08M |
| Cash, Cash Equivalents and Short-Term Investments | 22.16M | 22.31M | 17.76M | 19.75M | 21.79M | 19.34M |
| Total Debt | 24.27M | 26.28M | 23.42M | 26.06M | 27.98M | 30.32M |
| Total Liabilities | 42.80M | 43.95M | 42.23M | 46.29M | 45.83M | 48.98M |
| Stockholders Equity | 32.91M | 35.28M | 31.75M | 33.96M | 33.15M | 31.11M |
Cash Flow | ||||||
| Free Cash Flow | 15.34M | 12.07M | 10.48M | 9.56M | 13.59M | 14.36M |
| Operating Cash Flow | 17.21M | 14.14M | 13.47M | 13.14M | 15.84M | 16.25M |
| Investing Cash Flow | -1.87M | -1.59M | -2.82M | -3.58M | -2.24M | -1.85M |
| Financing Cash Flow | -12.39M | -8.48M | -12.65M | -11.63M | -12.11M | -5.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £56.05M | 3.42 | 20.89% | 0.55% | 2.64% | 23.89% | |
72 Outperform | £4.23B | 16.92 | 23.58% | 2.57% | 0.13% | -0.06% | |
68 Neutral | £37.54M | 8.53 | 12.14% | 11.65% | -3.45% | -44.02% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £303.88M | 4.43 | 9.74% | ― | 4.38% | ― | |
49 Neutral | £39.38M | 9.31 | -22.13% | 3.45% | -4.23% | -435.86% | |
47 Neutral | £34.51M | -0.69 | -26.39% | ― | -11.65% | -273.57% |